Helio Tedesco Silva Junior

Quick facts

Marketed products

• Conversion from Tacrolimus to Sirolimus · Immunology / Transplantation
  Conversion from tacrolimus to sirolimus involves switching from a calcineurin inhibitor to an mTOR inhibitor, both immunosuppressive agents used to prevent organ rejection.
• Maintenance on tacrolimus

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Helio Tedesco Silva Junior portfolio CI brief
• Helio Tedesco Silva Junior pipeline updates RSS